Cargando…

Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry

Acrylamide (AA) is a carcinogenic substance found in food, cigarette smoke and in an environment exposed to acrylamide. This study aims to analyze AA levels in dried blood spot (DBS) samples of lung cancer patients with smoking record, without smoking record, and also in the negative blank. Analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Harahap, Yahdiana, Elysia, Camilla, Starlin, Zenshiny, Jayusman, Achmad Mulawarman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254088/
https://www.ncbi.nlm.nih.gov/pubmed/32508924
http://dx.doi.org/10.1155/2020/2015264
_version_ 1783539462394871808
author Harahap, Yahdiana
Elysia, Camilla
Starlin, Zenshiny
Jayusman, Achmad Mulawarman
author_facet Harahap, Yahdiana
Elysia, Camilla
Starlin, Zenshiny
Jayusman, Achmad Mulawarman
author_sort Harahap, Yahdiana
collection PubMed
description Acrylamide (AA) is a carcinogenic substance found in food, cigarette smoke and in an environment exposed to acrylamide. This study aims to analyze AA levels in dried blood spot (DBS) samples of lung cancer patients with smoking record, without smoking record, and also in the negative blank. Analysis of AA levels was determined by liquid chromatography tandem mass spectrometry (LC-MS/MS) and DBS extraction using protein precipitation techniques. Mass detection was done using positive electron spray ionization (ESI) and multiple reaction monitoring (MRM) type with m/z values of 71.99 > 55.23 for acrylamide and m/z 260.16 > 116.04 for propranolol as the internal standard. AA levels in lung cancer patients with smoking record is in the range of 4.670 μg/mL to 11.986 μg/mL. AA levels in lung cancer patients without smoking record is in the range of 2.041 μg/mL to 12.702 μg/mL. Data on AA levels on negative blanks is in the range of 2.72 μg/mL to 3.51 μg/mL. The results of the independent sample t-test (p > 0.05) showed that AA levels in patients with smoking record and those without smoking record did not differ significantly. Then, the Mann-Whitney test was performed between the lung cancer group and the negative blank group and a significant difference was found between the two groups (p < 0.05).
format Online
Article
Text
id pubmed-7254088
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72540882020-06-05 Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry Harahap, Yahdiana Elysia, Camilla Starlin, Zenshiny Jayusman, Achmad Mulawarman Int J Anal Chem Research Article Acrylamide (AA) is a carcinogenic substance found in food, cigarette smoke and in an environment exposed to acrylamide. This study aims to analyze AA levels in dried blood spot (DBS) samples of lung cancer patients with smoking record, without smoking record, and also in the negative blank. Analysis of AA levels was determined by liquid chromatography tandem mass spectrometry (LC-MS/MS) and DBS extraction using protein precipitation techniques. Mass detection was done using positive electron spray ionization (ESI) and multiple reaction monitoring (MRM) type with m/z values of 71.99 > 55.23 for acrylamide and m/z 260.16 > 116.04 for propranolol as the internal standard. AA levels in lung cancer patients with smoking record is in the range of 4.670 μg/mL to 11.986 μg/mL. AA levels in lung cancer patients without smoking record is in the range of 2.041 μg/mL to 12.702 μg/mL. Data on AA levels on negative blanks is in the range of 2.72 μg/mL to 3.51 μg/mL. The results of the independent sample t-test (p > 0.05) showed that AA levels in patients with smoking record and those without smoking record did not differ significantly. Then, the Mann-Whitney test was performed between the lung cancer group and the negative blank group and a significant difference was found between the two groups (p < 0.05). Hindawi 2020-05-19 /pmc/articles/PMC7254088/ /pubmed/32508924 http://dx.doi.org/10.1155/2020/2015264 Text en Copyright © 2020 Yahdiana Harahap et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Harahap, Yahdiana
Elysia, Camilla
Starlin, Zenshiny
Jayusman, Achmad Mulawarman
Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry
title Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry
title_full Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry
title_fullStr Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry
title_full_unstemmed Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry
title_short Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry
title_sort analysis of acrylamide in dried blood spots of lung cancer patients by ultrahigh-performance liquid chromatography tandem mass spectrometry
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254088/
https://www.ncbi.nlm.nih.gov/pubmed/32508924
http://dx.doi.org/10.1155/2020/2015264
work_keys_str_mv AT harahapyahdiana analysisofacrylamideindriedbloodspotsoflungcancerpatientsbyultrahighperformanceliquidchromatographytandemmassspectrometry
AT elysiacamilla analysisofacrylamideindriedbloodspotsoflungcancerpatientsbyultrahighperformanceliquidchromatographytandemmassspectrometry
AT starlinzenshiny analysisofacrylamideindriedbloodspotsoflungcancerpatientsbyultrahighperformanceliquidchromatographytandemmassspectrometry
AT jayusmanachmadmulawarman analysisofacrylamideindriedbloodspotsoflungcancerpatientsbyultrahighperformanceliquidchromatographytandemmassspectrometry